(EVO) Evotec SE - Performance -24.7% in 12m
Compare EVO with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-73.43%
#110 in Group
Rel. Strength
26.38%
#5858 in Universe
Total Return 12m
-24.66%
#68 in Group
Total Return 5y
-67.55%
#73 in Group
P/E -
(?) Percentile in Group
P/E Forward 59.9
88th Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield 1.61%
67th Percentile in Group
12m Total Return: EVO (-24.7%) vs XBI (-12.3%)
5y Drawdown (Underwater) Chart
Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| UTHR NASDAQ United Therapeutics |
10.1% | 18% | 166% | 12.1 | 11 | 1.43 | 74.6% | 16.1% |
| HLN NYSE Haleon |
14.3% | 31.2% | 47% | 24.4 | 20.2 | 1.79 | 69.1% | 13.6% |
| AMGN NASDAQ Amgen |
-2.93% | -8.78% | 30.7% | 25.5 | 13.5 | 0.95 | 0.60% | 41% |
| LONN SW Lonza |
9.55% | 9.34% | 30.4% | 67.1 | 35.1 | 1.28 | 2.20% | -12.5% |
| BIM PA Biomerieux |
0.78% | 17.8% | -2.14% | 32.5 | 25.2 | 1.52 | -38.5% | -25.1% |
| KMDA NASDAQ Kamada |
21.4% | 25.3% | -4.13% | 26.6 | 23.9 | 0.96 | 32.5% | 3.93% |
| NBIX NASDAQ Neurocrine Biosciences |
34.3% | -15.5% | 3.48% | 32.3 | 21.6 | 0.27 | 68.0% | 31.9% |
| ERF PA Eurofins Scientific SE |
20.4% | -0.39% | 7.63% | 26.6 | 13.6 | 0.56 | -66.6% | -17.1% |
Performance Comparison: EVO vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for EVO
| Total Return (including Dividends) | EVO | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 28.62% | 11.81% | 13.81% |
| 3 Months | -13.50% | -13.61% | -6.30% |
| 12 Months | -24.66% | -12.29% | 10.65% |
| 5 Years | -67.55% | -24.89% | 107.77% |
| Trend Score (consistency of price movement) | EVO | XBI | S&P 500 |
| 1 Month | 71.3% | 72.9% | 83% |
| 3 Months | -41.6% | -83% | -75.3% |
| 12 Months | -37.0% | -51.6% | 50.1% |
| 5 Years | -87.2% | -53.9% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
| 1 Month | #16 | 15.0% | 13.0% |
| 3 Month | #55 | 0.13% | -7.68% |
| 12 Month | #68 | -14.1% | -31.9% |
| 5 Years | #76 | -56.8% | -84.4% |
FAQs
Does EVO Evotec SE outperforms the market?
No,
over the last 12 months EVO made -24.66%, while its related Sector, the SPDR S&P Biotech (XBI) made -12.29%.
Over the last 3 months EVO made -13.50%, while XBI made -13.61%.
Over the last 3 months EVO made -13.50%, while XBI made -13.61%.
Performance Comparison EVO vs Indeces and Sectors
EVO vs. Indices EVO is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -8.75% | 14.8% | -0.39% | -35.3% |
| US NASDAQ 100 | QQQ | -8.94% | 11.3% | -0.60% | -36.3% |
| US Dow Jones Industrial 30 | DIA | -9.16% | 18.6% | -0.10% | -32.4% |
| German DAX 40 | DAX | -8.73% | 13.7% | -26.7% | -50.4% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -10.9% | 16.8% | -1.16% | -32.0% |
| Hongkong Hang Seng | HSI | -11.9% | 8.69% | -8.75% | -38.3% |
| India NIFTY 50 | INDA | -3.83% | 23.8% | -0.83% | -24.5% |
| Brasil Bovespa | EWZ | -9.80% | 11.4% | -9.09% | -16.3% |
EVO vs. Sectors EVO is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -9.39% | 15.2% | -7.45% | -46.2% |
| Consumer Discretionary | XLY | -9.13% | 14.4% | 0.59% | -38.9% |
| Consumer Staples | XLP | -7.89% | 22.0% | -7.32% | -33.8% |
| Energy | XLE | -8.57% | 21.9% | 6.20% | -15.2% |
| Financial | XLF | -9.85% | 15.1% | -7.49% | -47.1% |
| Health Care | XLV | -5.74% | 27.8% | 4.60% | -20.6% |
| Industrial | XLI | -10.4% | 11.8% | -1.82% | -35.7% |
| Materials | XLB | -8.55% | 15.1% | 4.50% | -19.4% |
| Real Estate | XLRE | -7.43% | 17.1% | -1.14% | -40.1% |
| Technology | XLK | -9.83% | 7.40% | 2.49% | -31.8% |
| Utilities | XLU | -8.80% | 19.0% | -8.05% | -42.1% |
| Aerospace & Defense | XAR | -10.7% | 7.46% | -11.9% | -52.0% |
| Biotech | XBI | -2.16% | 16.8% | 19.8% | -12.4% |
| Homebuilder | XHB | -9.22% | 17.1% | 12.8% | -17.1% |
| Retail | XRT | -10.7% | 14.0% | 3.85% | -23.2% |